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Abstract: The acid-base equilibria of a diprotic, slightly hydrosoluble base ketoco-
nazole were studied in homogeneous and heterogeneous water systems. The deter-
minations were performed at 25 ºC at a constant ionic strength of 0.1 M (NaCl). The
acidity constant Ka1 was determined by potentiometric (pKa1 3.20) and spectropho-
tometric (pKa1 3.26) methods. A pKa2 constant of 6.10 was obtained based on the
equilibrium constants pKs0 4.84 and pKs1 –1.26, determined in a heterogeneous
ketoconazole system. The obtained values of the constants served to calculate the
solubility and the distribution of the equilibrium forms of ketoconazole as a function
of pH. On the basis of the distribution of the equilibrium forms of ketoconazole, a
spectrophotometric method for the determination of its content in commercial tab-
lets was developed. The determinations were performed at 225 nm in 0.1 M HCl.
The method is simple and rapid and enables the direct spectrophotometric determi-
nation of the content of ketoconazole without previous isolation.
Keywords: ketoconazole, acidity constants, heterogeneous equilibria, spectrophoto-
metric determination, pharmaceuticals.
INTRODUCTION
Ketoconazole (cis-1-acetyl-4-4-2-(2,4-dichlorophenyl)-2(1H-imidazol-1-ylme-
thyl)-1,3-dioxolan-4-ylmethoxy]phenylpiperazine) is an orally active, antimy-
cotic agent from the class of imidazole derivatives. It is active against Candida
spp., Cryptococcus neoformans and Pseudallescheria boydii.1,2 It is also effective
in the treatment of pityriasis versicolor. Ketoconazole is the only member of the
imidazole derivatives currently used for the treatment of systemic infections. The
continually increasing number of patients suffering from mycoses due to de-
creased immunity (AIDS, organ transplantations, etc.) has led to a rather frequent
application of pharmacologically active agents from this class.
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Chemically, ketoconazole is a diprotic base and its molecular form is slightly
hydrosoluble. Knowledge about the distribution of the equilibria and the solubility
of ketoconazole within the physiological pH range could help to understand better
the details of the mechanism underlying its action as a drug. Namely, the absorp-
tion of drugs in the gastrointestinal tract, as well as their transport through the cell
membranes depend on the properties of the chemical species involved. However,
there are no data in the available literature on the protolytic equilibria of ketoco-
nazole in homogeneous and heterogeneous aqueous systems and a part of this work
was devoted to these studies.
In addition, this study was aimed at demonstrating that examination of pro-
tolytic equilibria might be of importance in the analytics of ketoconazole, concern-
ing the choice of methodological approaches and the conditions for its direct spec-
trophotometric determination. Several spectrophotometric methods for the deter-
mination of ketoconazole have been described to date.3–11 These methods were
based on the formation and extraction of ionic pairs or complexes by a suitable re-
agent. Only Kedor-Hackmann et al.3 proposed a direct spectrophotometric method
for the determination of ketoconazole in pharmaceutical preparations.
EXPERIMENTAL
Apparatus
For the spectrophotometric measurements, a GBC Cintra 40 spectrophotometer with 1.0 cm
quartz cells was used. A PHM240 pH meter (Radiometer) with a combined GK2401B electrode (Ra-
diometer) served to determine the pH values. Titrations were performed with a TTT-60 titrator and
an ABU-12 autoburette (Radiometer).
Reagents
Ketoconazole (KC) of pharmaceutical purity, a product of Medilom & Co. (Antwerpen, Bel-
gium) was kindly supplied by The Institute of Pharmacy of Serbia (Belgrade, Serbia and Monte-
negro). All other reagents (HCl, NaOH and NaCl), products of Merck (Darmstadt, Germany), were
of analytical grade purity. Solutions of HCl and NaOH were standardized potentiometrically.
The examined tablets, Mycoseb® (“Zorka Pharma”, [abac, Serbia and Montenegro), Nizoral®
(Janssen Pharmaceutica, Beerse, Belgium) and Oronazol® (“Krka”, Novo Mesto, Slovenia), con-
tained 200 mg ketoconazole each.
Determination of the equilibrium constants
The equilibrium constants in homogeneous and heterogeneous systems of ketoconazole were
determined at 25.0  0.1 ºC and constant ionic strength of 0.1 M (NaCl).
Potentiometric determination of Ka1. 20 mL of solution containing 110
-3 M of ketoconazole
and 510-3 M of HCl was titrated with standard NaOH solution (0.07072 M) in 0.050 mL aliquots.
The function of formation (n) was calculated using the following equation:
n =
c cHCl NaOH H3O
+
KC
  [ ]
c
(1)
where cKC, cHCl and cNaOH represent the concentration of ketoconazole, HCl and NaOH in the titrated
solution, respectively; [H3O
+] is the equilibrium concentration of hydronium ions obtained from the
measured pH values. The obtained pH values were converted into pcH according to equation:
12 pcH =
–log[H3O
+] = pH – A. For an ionic strength of 0.1 M (NaCl) at 25 ºC, the correction factor A was 0.12.
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Spectrophotometric determination of Ka1. A series of ketoconazole solutions of the same stoichio-
metric concentration (cKC = 4
-5 M) within the pH range from 1.0 to 4.2 was prepared. The acidity
was adjusted with HCl. The spectra of the solutions were recorded against the corresponding blanks. The
absorbances measured at 242 nm were further used for the calculations of the acidity constants.
Determination of the equilibrium constants in heterogeneous system. Saturated ketoconazole
solutions of pH 5.5–6.5 were prepared by treating an excess of the solid base with an HCl solution
and adding NaCl up to an ionic strength 0.1 M, while those having pH of 8.5–10 were obtained by
treating an excess of the solid base with 0.1 M NaCl and adding NaOH solution. The samples were
thermostated at 25 ºC with occassional stirring until complete equilibration was achieved (4 h). Af-
ter pH measurement, the solutions were separated from the insoluble part by filtration. Aliquots of
the filtrate were diluted with 0.1 M HCl. The concentration of the diprotonated form of ketoconazole
(BH2
2+) was determined spectrophotometrically at 225 nm, conformity with Beer’s law having been
previously verified.
Determination of ketoconazole in tablets
Standard solutions. A stock ketoconazole solution (500 g/mL) was prepared by dissolving
the solid substance in 0.1 M HCl. Aliquots of 0.15, 0.25, 0.50, 0.75, 1.00 and 1.50 mL of this solu-
tion were transferred into 25 mL volumetric flasks and 0.1 M HCl was added to the volume. The
absorbances of the solutions were measured at 225 nm against 0.1 M HCl as the blank.
Sample solutions. Ten tablets were weighed and powdered; the mass containing 50 mg
ketoconazole was taken and quantitatively transferred into a 100 mL volumetric flask containing ap-
proximately 80 mL 0.1 M HCl. After 5-min-treatment in an ultrasonic bath, 0.1 M HCl was added to
the volume. The resulting suspension was filtered (blue stripe filter paper) and the first 10 mL of the
filtrate were discarded. Aliquots of 0.5 mL were taken from the remaining filtrate, transferred into
25 mL volumetric flasks and diluted with 0.1 M HCl to the volume. Absorbances of the solutions
were measured at 225 nm against 0.1 M HCl as the blank.
RESULTS AND DISCUSSION
Protolytic equilibria in homogeneous and heterogeneous system
The piperazine nitrogen atom N-26 and the imidazole nitrogen atom N-11 repre-
sent the two basic centers of a ketoconazole molecule which participate in protolytic
reactions wihtin the pH range from 0 to 14. Based on the comparison with aniline (pKa
4.6) and imidazole (pKa 6.9) as model compounds, it can be concluded that the
imidazole nitrogen atom has a higher affinity for a proton (see Scheme 1).
The corresponding acidity constants are defined as:
Ka1 =
[H O ][BH ]
[BH ]
3
+ +
2
2+
(2)
Ka2 =
[H O ][B]
[BH ]
3
+
+
(3)
Since ketoconazole is slightly hydrosoluble in its molecular form, in the heter-
ogeneous system between the solid base (Bs) and the saturated aqueous solution,
the following equilibria are established:
DETERMINATION OF KETOCONAZOLE 69
Bs B Ks0 = [B] (4)
Bs + H3O
+
BH
+
+ H2O Ks1 =
[BH ]
[H O ]
+
3
+
(5)
Bs + 2 H3O
+ BH2
2+ + 2H2O Ks2 =
[BH ]
[H O ]
2
2+
3
+ 2
(6)
The following relations between the acidity constants and the constants in a
heterogeneous system exist:
Ka1 =
K
K
s1
s2
(7)
Ka2 =
K
K
s0
s1
(8)
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Scheme 1.
	


	


Taking into account the expected difference in the basicity of N-26 and N-11,
it was possible to determine the acidity constants of ketoconazole independently
within different pH ranges with a single acid-base pair predominating.
Since ketoconazole is stable in acidic medium and its protonated forms BH2
2+
and BH+ are soluble, it was possible to determine the acidity constant Ka1 by a
potentiometric and a spectrophotometric method.
For potentiometric determination of Ka1, the method of bound protons
13 was
applied. The determinations were performed within the pH range from 3.0–4.0
where acid-base pair BH2
2+ – BH+ is dominant. The formation function (n), i.e.,
the average number of protons bound to the base, can be expressed by the follow-
ing equation:
n =
2[ ] [ ]
[ ] [
BH BH
BH BH ]
2
2+ +
2
2+ +


(9)
By combining Eqs. (2) and (9), the following equation can be obtained:
2
1
1
1



n
n
K a
[ ]H O3
+
(10)
On the basis of the experimentally determined value of the formation function
at different pH values and Eq. (10), the value of Ka1 was calculated by regression
analysis from the slope of the plot of (2–n)/(n–1) against 1/H3O
+
 (Fig. 1). The
obtained pKa1 was 3.20.
The optimal conditions for the spectrophotometric determination of Ka1 were
chosen by analyzing the ketoconazole spectra obtained in solutions of different
acidity (Fig. 2). From the ketoconazole spectra at pH 1.0 and 4.0, it can be con-
cluded that the biggest difference in the spectra which follows protonation of the
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Fig. 1. Potentiometric determination
of Ka1 constant of ketoconazole ap-
plying Eq. (10).
N-26 atom was observed at approximately 240 nm. To calculate Ka1, a transformed
classical spectrophotometric equation14 was employed:
A = A
KBH a


1
1
[H3O
+
](A – ABH22+) (11)
where ABH+ and ABH22+ represent the absorbances of pure ketoconazole forms BH
+
and BH2
2+, and A are the absorbances of their mixtures at a certain H3O
+
. For the
determination of the constant by this equation, it was necessary to know the spec-
trum of the single “pure” form of BH2
2+. Absorption spectra used to determine Ka1
are shown in Fig. 3. The absorbances of the ketoconazole solution at 242 nm and Eq.
(11) served to calculate the value of Ka1 by regression analysis from the slope of the
linear plot shown in Fig. 4. In this way, a pKa1 value of 3.26 was obtained.
Acidity constant Ka2 of ketoconazole was impossible to determine spectro-
photometrically because of the small differences between the absorption spectra
(Fig. 2) which follow protonation of the imidazole nitrogen atom (the spectra of
ketoconazole solutions pH 6.5 and 10.0). It was also impossible to determine this
constant potentiometrically because the molecular form of ketoconazole is only
sparingly soluble in aqueous media. Thus, pKa2 was indirectly determined on the
basis of the equilibria in a heterogeneous system.
The equilibrium constants in a heterogeneous system were estimated by ap-
plying the solubility method. The determination was performed within two differ-
ent pH ranges from 5.5–6.5 (the BH+ and B forms of ketoconazole are present in
saturated solution) and at pH > 8.5 (the molecular form of ketoconazole, B, is dom-
inant in saturated solution). The relationship between the solubility (S) and the
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Fig. 2. Absorption spectra of ketoconazole (1.5  10-5 M) in solutions of different acidity. 1)
0.1–1 M HCl (BH2
2+ form); 2) pH 4.0; 3) pH 6.5; 4) pH 10.0 (B form).
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Fig 4. Spectrophotometric de-
termination of Ka1 constant of
ketoconazole applying Eq. (11).
Fig. 3. Absorption spectra of the ketoconazole solution (4  10-5 M) used to determine the value
of Ka1. pH: 1) 1.0 (BH2
2+ form); 2) 2.51; 3) 2.71; 4) 2.96; 5) 3.14; 6) 3.36; 7) 4.20.
Fig. 5. Determination of the
constants Ks0 and Ks1 of ke-
toconazole applying Eq. (13).
corresponding equilibrium constants (Eqs. (4) and (5)) can be expressed by the fol-
lowing equations:
S = B + BH+ = Ks0 + Ks1H3O
+
 (pH 5.5–6.5) (13)
S = B = Ks0 (pH > 8.5) (14)
On the basis of experimentally determined solubility within the pH range from
5.5 to 6.5 and by application of Eq. (13), the values of Ks0 and Ks1 were determined
from the intercept and the slope of the linear plot shown in Fig. 5. Equation (14)
shows that the solubility of ketoconazole in alkaline media should be constant
(equal to the value of Ks0).
The equilibrium constant Ka2 was calculated according to the determined con-
stants Ks0 and Ks1 and Eq. (8).
TABLE I. The concentration equilibrium constants in homogeneous and heterogeneous systems of
ketoconazole. t = 25 ºC; I = 0.1 M (NaCl)
Constant Value* Equation applied
pKa1 3.20 ± 0.01 (10)
3.26 ± 0.03 (11)
pKa2 6.10 ± 0.07 (8)
pKs0 4.84 ± 0.06 (14)
pKs0 4.5 ± 0.2 (13)
pKs1 –1.26 ± 0.03 (13)
pKs2 – 4.46 ± 0.03 (7)
*pK ± sd
The equilibrium constants determined in homogeneous and heterogeneous
ketoconazole systems are summarized in Table I. As can be seen, the values of Ka1
obtained by the two independent methods corresponded well. The value of Ks0 was
estimated by two approaches and more precise results were obtained when Eq. (14)
was applied. Hence, this value was used to calculate the acidity constant Ka2. The
equilibrium constants determined in a heterogeneous system can be used to calcu-
late the solubility of ketoconazole in dependence of the acidity:
S = B + BH+ + BH2
2+
 = Ks0 + Ks1H3O
+
 + Ks2H3O
+

2 (15)
as well as the distribution of the equilibrium particles:
BH2
2+ =
[ ]
[ ] [ ]
H O
H O H O
3
+
3
+
a 3
+
a a
2
2
1 1 2 K K K
(16)
BH
+ =
K
K K K
a1 3
+
3
+
a 3
+
a a
H O
H O H O
[ ]
[ ] [ ]
2
1 1 2 
(17)
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BH =
K K
K K K
a a
3
+
a 3
+
a aH O H O
1 2
2
1 1 2[ ] [ ] 
(18)
The distribution of the equilibrium forms of ketoconazole as a function of pH
is depicted in Fig. 6. The relative concentrations of the equilibrium forms of
ketoconazole at three biologically important pH values are summarized in Table II.
At pH 1.0, 99.3 % of the ketoconazole was present as the diprotonated form, while
the other forms were only minor components. At pH 7.4 and 9.0, the molecular
form of ketoconazole was dominant.
TABLE II. The equilibrium percentage distribution of ketoconazole species at physiologically im-
portant pH values
pH 1 7.4 9
BH2
2+ 99.3 6.0 10-3 1.510-4
BH
+ 6.610-1 5.3 1.310-1
B 1.110
-5 94.6 99.8
Spectrophotometric determination of ketoconazole in tablets
The choice of the optimal conditions for the determination of ketoconazole
was made based on the distribution of its equilibrium forms (Fig. 6), as well as
spectral characteristics (Fig. 2). From Fig. 6, it can be seen that ketoconazole in the
form of a single species occurs at pH under 1.2 (BH2
2+ form) and over 8.1 (B
form). Direct spectrophotometric determination of ketoconazole after Kedor-Hac-
kmann et al.,3 was performed in a solution of pH 2 (0.01 M HCl) at 222 nm. At this
pH value, ketoconazole mainly occurs in the diprotonated form. However, the con-
centration of the monoprotonated form under these conditions can not be ne-
glected. Hence, in the present study, 0.1 M HCl was chosen as the optimal medium.
Determinations were performed at 225 nm since this wavelength corresponds to
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Fig. 6. Distribution of the forms
of ketoconazole as a function
of pH.
the absorption maximum of the BH2
2+ form of ketoconazole. A calibration curve
was obtained within the range of ketoconazole concentrations from 3 to 30 g/mL:
A = (– 0.003  0.006) + (0.0525  0.0004) c (r = 0.9999) (19)
where c is the concentration expressed in g/mL.
TABLE III. Spectrophotometric determination of ketoconazole
Taken
g/mL
Found
g/mL
RSD*
%
Recovery
%
5.00 4.96 0.98 99.2
10.00 10.05 0.65 100.5
20.00 20.18 0.76 100.9
*n = 6
The accuracy and precision of the method were checked by analyzing three
ketoconazole solutions of different concentration. The results (6 independent de-
terminations of each ketoconazole solution) are summarized in Table III. The re-
covery and low values of the relative standard deviation indicate a satisfactory
reproducibility of this method.
TABLE IV. The level of ketoconazole in commercial tablets. Label claim 200 mg ketoconazole per
tablet
Preparation Found
mg per tablet
RSD*
%
Label claim
%
Mycoseb® 199.1 1.39 99.5
Nizoral® 203.2 1.13 101.6
Oronazol® 203.0 1.25 101.5
*n = 6
The applicability of the method was tested by determining ketoconazole in the
following commercial ketoconazole-containing tablets: Mycoseb®, Nizoral® and
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Fig. 7. Absorption spectra of
ketoconazole (10 g/mL) in
0.1 M HCl solutions: 1) Ke-
toconazole standard, 2) My-
coseb® tablets, 3) Nizoral®
tablets, 4) Oronazol® tablets.
Oronazol®. The absorption spectra of a ketoconazole standard and solutions of the
examined tablets are presented in Fig. 7. As can be seen, at wavelengths above 205
nm, the absorption spectra overlap. This demonstrates the absence of interference
of other substances present in the examined tablets. The results of ketoconazole de-
termination in tablets are listed in Table IV.
The proposed method for the determination of ketoconazole in pharmaceuti-
cal formulations is precise, rapid and simple. It enables the direct spectrophotomet-
ric determination of ketoconazole in tablets without previous isolation. In addition,
this method does not require the use of expensive equipment and toxic reagents
thus fulfilling the concept of Green Chemistry.
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I Z V O D
PROTOLITI^KE RAVNOTE@E U HOMOGENOM I HETEROGENOM
SISTEMU KETOKONAZOLA I WEGOVO DIREKTNO
SPEKTROFOTOMETRIJSKO ODRE\IVAWE U TABLETAMA
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Prou~ene su kiselinsko-bazne ravnote`e u homogenom i heterogenom vodenom
sistemu ketokonazola, diproti~ne te{ko rastvorne baze. Odre|ivawa su vr{ena na
temperaturi 25 ºC i pri konstantnoj jonskoj sili 0,1 M (NaCl). Kiselinska konstanta Ka1
odre|ena je potenciometrijski (pKa1 3,20) i spektrofotometrijski (pKa1 3,26). Kon-
stanta pKa2 6,10 izra~unata je iz ravnote`nih konstanti odre|enih u heterogenom
sistemu: pKs0 4,84 i pKs1 –1,26. Na osnovu dobijenih vrednosti za konstante izra~unata je
rastvorqivost i raspodela ravnote`nih oblika ketokonazola u funkciji pH. Na bazi
raspodele ravnote`nih oblika ketokonazola predlo`ena je spektrofotometrijska
metoda za wegovo odre|ivawe u komercijalnim tabletama. Odre|ivawa su vr{ena na
talasnoj du`ini 225 nm u 0,1 M HCl. Metoda je jednostavna i brza, i omogu}ava direktno
spektrofotometrijsko odre|ivawe ketokonazola, bez prethodnog izolovawa.
(Primqeno 13. februara, revidirano 7. juna 2004)
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